Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Steven Madden
SHOO
$3.58B
| $2.3M | ﹤0.01% |
93,047
+14,432
| +18% | +$338K |
|
1977
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
| $2.3M | ﹤0.01% |
77,300
-123,000
| -61% | -$3.4M |
|
1978
CALL
Freeport-McMoran
FCX
$98.7B
| $2.3M | ﹤0.01% |
198,500
-754,400
| -79% | -$6.91M |
|
1979
American Financial Group
AFG
$11.9B
| $2.29M | ﹤0.01% |
36,092
-49,061
| -58% | -$3.16M |
|
1980
CoreCivic
CXW
$3.26B
| $2.29M | ﹤0.01% |
244,660
+147,604
| +152% | +$1.68M |
|
1981
CALL
Kinder Morgan
KMI
$69.9B
| $2.29M | ﹤0.01% |
150,800
-215,300
| -59% | -$3.27M |
|
1982
Cardlytics
CDLX
$22.3M
| $2.29M | ﹤0.01% |
3,267
+9
| +0.3% | +$5.2K |
|
1983
PUT
American Eagle Outfitters
AEO
$3.07B
| $2.28M | ﹤0.01% |
209,500
+150,100
| +253% | +$1.42M |
|
1984
CALL
Direxion Daily Financial Bull 3x ETF
FAS
$2.45B
| $2.28M | ﹤0.01% |
72,900
-167,900
| -70% | -$4.96M |
|
|
CADE
1985
DELISTED
Cadence Bank
CADE
| $2.28M | ﹤0.01% |
100,275
+24,821
| +33% | +$527K |
|
|
SHLX
1986
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $2.28M | ﹤0.01% |
185,851
+165,698
| +822% | +$2.13M |
|
1987
LPL Financial
LPLA
$29.3B
| $2.28M | ﹤0.01% |
29,048
-513,068
| -95% | -$34.3M |
|
1988
Healthcare Services Group
HCSG
$1.49B
| $2.28M | ﹤0.01% |
93,166
+17,113
| +23% | +$405K |
|
1989
PBF Energy
PBF
$7.86B
| $2.28M | ﹤0.01% |
222,325
+45,058
| +25% | +$450K |
|
|
BHVN
1990
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.28M | ﹤0.01% |
31,144
-168,260
| -84% | -$8.95M |
|
1991
PUT
Knight Transportation
KNX
$11.2B
| $2.27M | ﹤0.01% |
54,500
-78,800
| -59% | -$3.01M |
|
|
CLR
1992
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.27M | ﹤0.01% |
129,380
-366,705
| -74% | -$5.15M |
|
1993
Rhythm Pharmaceuticals
RYTM
$7.95B
| $2.27M | ﹤0.01% |
101,851
+8,127
| +9% | +$158K |
|
|
STPP
1994
DELISTED
iPath US Treasury Steepener ETN
STPP
| $2.27M | ﹤0.01% |
89,000
| – | – |
|
1995
PUT
Burlington
BURL
$23.4B
| $2.27M | ﹤0.01% |
11,500
-15,200
| -57% | -$2.86M |
|
|
PRSP
1996
DELISTED
Perspecta Inc. Common Stock
PRSP
| $2.26M | ﹤0.01% |
97,453
+43,361
| +80% | +$946K |
|
1997
CALL
A.O. Smith
AOS
$8.48B
| $2.26M | ﹤0.01% |
48,000
+46,400
| +2,900% | +$2.03M |
|
1998
Green Dot
GDOT
$753M
| $2.25M | ﹤0.01% |
45,914
+4,840
| +12% | +$164K |
|
1999
CALL
Colgate-Palmolive
CL
$74.3B
| $2.25M | ﹤0.01% |
30,700
-230,700
| -88% | -$16.4M |
|
2000
Madrigal Pharmaceuticals
MDGL
$11.9B
| $2.25M | ﹤0.01% |
19,837
+1,439
| +8% | +$142K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.